GTS Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-173,300
Closed -$28.1M 2710
2024
Q3
$28.1M Sell
173,300
-23,600
-12% -$3.76M 0.06% 191
2024
Q2
$28.8M Sell
196,900
-41,400
-17% -$6.16M 0.06% 188
2024
Q1
$37.7M Buy
238,300
+19,400
+9% +$3.09M 0.07% 141
2023
Q4
$34.3M Sell
218,900
-165,500
-43% -$25.4M 0.06% 201
2023
Q3
$59.9M Buy
+384,400
New +$63.4M 0.11% 88

Other funds holding JNJ

GTS Securities's JNJ Position: Q1 2026 in Review

GTS Securities reduced its Johnson & Johnson (JNJ) stake by 65% in Q1 2026, selling an estimated $5.08M and leaving 11,972 shares worth $2.93M. The position accounts for 0.1% of the portfolio, ranked #133.

GTS Securities first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. The position peaked at $24.3M in Q2 2023. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • GTS Securities held 11,972 shares of Johnson & Johnson worth $2.93M as of Q1 2026.
  • GTS Securities sold 21,808 Johnson & Johnson shares in Q1 2026, an estimated $5.08M.
  • Johnson & Johnson made up 0.1% of GTS Securities's portfolio in Q1 2026, its #133 holding.
  • GTS Securities first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Johnson & Johnson position peaked at $24.3M in Q2 2023.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.